Pharma Compliance CEE,Radisson Blu Hotel, Istanbul Asia, Istanbul, Turkey
Compliance Strategy for Pharma - Pharma Compliance CEE

Mr Karl Boonen | Senior Director of Business Practices and Compliance E.M.E.A. and Canada
Johnson and Johnson | Belgium

Mr Karl Boonen, Senior Director of Business Practices and Compliance E.M.E.A. and Canada, Johnson and Johnson

Karl Boonen currently is Senior Director Business Practices & Compliance EMEA and Canada at Johnson & Johnson, primarily responsible for Third Party Intermediary Risk Management.
He started his career with Unilever in marketing and market research and joined J&J in 1985.
He spent 25 years in Pharma covering a wide array of responsibilities including Area Management South-East Asia, incl. Australia and New Zealand; Sales and Marketing in Canada en Switzerland; Operations (international logistics and manufacturing); Finance; Logistics; Health Care Solutions and Business Support incl. channel strategy and anti-counterfeit.
At the end of 2010, Karl joined Health Care Compliance and Privacy to take up his current role.
Karl earned a Masters Degree in Law (Leuven) and in Management (Vlerick Ghent) and also obtained an Executive Master in Innovation and Entrepreneurship (Vlerick Leuven-Ghent).
He is a Certified Compliance & Ethics Professional (CCEP) and a member of ETHICS (International Society of Healthcare Ethics and Compliance Professionals).

Share this

Appearances coming up:

Thursday, 5th June


@ 11.00
Due diligence and risk management of TPIs

@ 11.30
PANEL: Global Anti-bribery policies, due diligence and monitoring

sponsors
Gold Sponsor
BMI System at Pharma Compliance CEE
Silver Sponsor
Thomson Reuters Accelus at Pharma Compliance CEE